BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 25, 2026
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: Corcept’s Lifyorli wins early FDA approval for ovarian cancer
Breaking News: Trump administration impacts continue to roil the life sciences sector
Home
»
Topics
» BioWorld Science, Neurology/psychiatric
BioWorld Science, Neurology/psychiatric
RSS
Anxiolytic/antidepressant 5-HT1A receptor ligands from AHP
July 5, 1996
Lilly's 5-HT1F agonists for migraine
July 5, 1996
CRF earns positive results in phase I/II
June 28, 1996
Cypros is granted U.S. patent for CPC-211 dosing regimen
June 28, 1996
Lifarizine shows positive results in efficacy/safety study
June 28, 1996
Suntory describes metabotropic glutamate antagonists
June 28, 1996
RPR reports glutamate antagonists
June 28, 1996
NMDA antagonists synthesized by Hoechst Marion Roussel
June 28, 1996
Takeda seeks German approval for idebenone
June 28, 1996
Ampalex proves effective and safe
June 28, 1996
Previous
1
2
…
2770
2771
2772
2773
2774
2775
2776
2777
2778
…
2796
2797
Next
RSS